OCD. Obsessive-compulsive disorder
Conditions
Interventions
Intervention 1: Drug Group , atorvastatin. Intervention 2: Placebo group , similar to Atorvastatin (Starch).
Treatment - Drugs
Placebo
Drug Group , atorvastatin
Placebo group , similar to Atorvastatin (Starch)
Sponsors
Deputy for Reaserch and Techonology
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: resistant OCD (a patient should undergo continuous monotherapy treatment with SSRIs for three months in order to be defined as resistant); Signing inform consent. Exclusion criteria: the patients did not have any innate neurological disorders, and laboratory test results for blood count; liver and renal functions were abnormal; a A minimum score of 21 in the Yale–Brown Scale (Y-BOCS) for OCD; breast feeding; pregnant women.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Yale brown Scale. Timepoint: 0 and 12th week after intervention. Method of measurement: Questionnaire completed by psychiatrist. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effect. Timepoint: 0 and 12th week after intervention. Method of measurement: Patients' medical report. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Sayyah Bargard
Jundishapur University of Medical Sciences
Outcome results
None listed